My Account Log in

2 options

Reintroduce Thalidomide? (B) / Daniel Diermeier, Jason Hermitage, Shail Thaker, Justin Heinze.

Online

Available online

View online

SAGE Business Cases 2016-2019 Available online

View online
Format:
Book
Author/Creator:
Diermeier, Daniel, author.
Hermitage, Jason, author.
Thaker, Shail, author.
Heinze, Justin, author.
Series:
SAGE Knowledge. Cases.
SAGE Knowledge. Cases
Language:
English
Subjects (All):
Immunopharmacology.
Thalidomide.
United States. Food and Drug Administration.
United States.
Physical Description:
1 online resource : illustrations.
Place of Publication:
London : Kellogg School of Management, 2006.
System Details:
text file
Summary:
The case explains how and why Thalidomide was at last licensed by the FDA and how this would benefit the manufacturer of the drug Celgene.
Notes:
Originally published in Diermeier, D., Hermitage, J., Thaker, S., & Heinze, J. (2006). Reintroduce thalidomide? (B). 5-104-003(B). Evanston, IL: Kellogg School of Management at Northwestern University.
No ILL or scholarly sharing allowed.
Description based on XML content.
ISBN:
9781526449818
OCLC:
1023537886
Access Restriction:
Restricted for use by site license.

The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.

My Account

Shelf Request an item Bookmarks Fines and fees Settings

Guides

Using the Library Catalog Using Articles+ Library Account